Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
Children have been infected in greater numbers in the latest coronavirus wave driven by the Delta variant, and inoculating young people is seen as key to keeping schools open and helping end the pandemic.
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
Children have been infected in greater numbers in the latest coronavirus wave driven by the Delta variant, and inoculating young people is seen as key to keeping schools open and helping end the pandemic.
In late September, Pfizer and BioNTech, the German biotechnology giant which co-developed the vaccine, began submitting data to Food and Drug Administration regulators for the highly anticipated authorization.
Pfizer tweeted early Thursday that the two companies had "officially submitted our request" to the FDA "for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to
Children have been infected in greater numbers in the latest coronavirus wave driven by the Delta variant, and inoculating young people is seen as key to keeping schools open and helping end the pandemic.
In late September, Pfizer and BioNTech, the German biotechnology giant which co-developed the vaccine, began submitting data to Food and Drug Administration regulators for the highly anticipated authorization.
Pfizer tweeted early Thursday that the two companies had "officially submitted our request" to the FDA "for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to
